Literature DB >> 25252914

Cancer-associated adipose tissue promotes breast cancer progression by paracrine oncostatin M and Jak/STAT3 signaling.

Lore Lapeire1, An Hendrix2, Kathleen Lambein3, Mieke Van Bockstal3, Geert Braems4, Rudy Van Den Broecke4, Ridha Limame5, Pieter Mestdagh6, Jo Vandesompele6, Christian Vanhove7, Dawn Maynard8, Camille Lehuédé9, Catherine Muller9, Philippe Valet10, Christian P Gespach11, Marc Bracke2, Veronique Cocquyt1, Hannelore Denys1, Olivier De Wever12.   

Abstract

Increasing evidence supports the critical roles played by adipose tissue in breast cancer progression. Yet, the mediators and mechanisms are poorly understood. Here, we show that breast cancer-associated adipose tissue from freshly isolated tumors promotes F-actin remodeling, cellular scattering, invasiveness, and spheroid reorganization of cultured breast cancer cells. A combination of techniques, including transcriptomics, proteomics, and kinomics enabled us to identify paracrine secretion of oncostatin M (OSM) by cancer-associated adipose tissue. Specifically, OSM, expressed by CD45(+) leucocytes in the stromal vascular fraction, induced phosphorylation of STAT3 (pSTAT3-) Y705 and S727 in breast cancer cells and transcription of several STAT3-dependent genes, including S100 family members S100A7, S100A8, and S100A9. Autocrine activation of STAT3 in MCF-7 cells ectopically expressing OSM-induced cellular scattering and peritumoral neovascularization of orthotopic xenografts. Conversely, selective inhibition of OSM by neutralizing antibody and Jak family kinases by tofacitinib inhibited STAT3 signaling, peritumoral angiogenesis, and cellular scattering. Importantly, nuclear staining of pSTAT3-Y705 identified at the tumor invasion front in ductal breast carcinomas correlates with increased lymphovascular invasion. Our work reveals the potential of novel therapeutic strategies targeting the OSM and STAT3 axis in patients with breast cancer harboring nuclear pSTAT3-Y705. ©2014 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25252914     DOI: 10.1158/0008-5472.CAN-14-0160

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  49 in total

1.  Interleukin-8 Activates Breast Cancer-Associated Adipocytes and Promotes Their Angiogenesis- and Tumorigenesis-Promoting Effects.

Authors:  Huda H Al-Khalaf; Bothaina Al-Harbi; Adher Al-Sayed; Maria Arafah; Asma Tulbah; Abdulaziz Jarman; Falah Al-Mohanna; Abdelilah Aboussekhra
Journal:  Mol Cell Biol       Date:  2019-01-03       Impact factor: 4.272

2.  The isolation of morphologically intact and biologically active extracellular vesicles from the secretome of cancer-associated adipose tissue.

Authors:  Sarah Jeurissen; Glenn Vergauwen; Jan Van Deun; Lore Lapeire; Victoria Depoorter; Ilkka Miinalainen; Raija Sormunen; Rudy Van den Broecke; Geert Braems; Véronique Cocquyt; Hannelore Denys; An Hendrix
Journal:  Cell Adh Migr       Date:  2017-02-01       Impact factor: 3.405

3.  Co-culture With Human Breast Adipocytes Differentially Regulates Protein Abundance in Breast Cancer Cells.

Authors:  Rebekah Lee Isla Crake; Elisabeth Phillips; Torsten Kleffmann; Margaret Jane Currie
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

4.  STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.

Authors:  Benjamin L Bryson; Damian J Junk; Rocky Cipriano; Mark W Jackson
Journal:  Cell Cycle       Date:  2016-11-28       Impact factor: 4.534

5.  Increased Expression of Beige/Brown Adipose Markers from Host and Breast Cancer Cells Influence Xenograft Formation in Mice.

Authors:  Rajan Singh; Meher Parveen; John M Basgen; Sayeda Fazel; Meron F Meshesha; Easter C Thames; Brandis Moore; Luis Martinez; Carolyn B Howard; Laurent Vergnes; Karen Reue; Shehla Pervin
Journal:  Mol Cancer Res       Date:  2015-10-13       Impact factor: 5.852

Review 6.  The Role of Adipokines in Breast Cancer: Current Evidence and Perspectives.

Authors:  Gerasimos Socrates Christodoulatos; Nikolaos Spyrou; Jona Kadillari; Sotiria Psallida; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2019-12

7.  S100A7 has an oncogenic role in oral squamous cell carcinoma by activating p38/MAPK and RAB2A signaling pathway.

Authors:  K K Dey; R Bharti; G Dey; I Pal; Y Rajesh; S Chavan; S Das; C K Das; B C Jena; P Halder; J G Ray; I Kulavi; M Mandal
Journal:  Cancer Gene Ther       Date:  2016-10-21       Impact factor: 5.987

8.  JAK1/STAT3 Activation through a Proinflammatory Cytokine Pathway Leads to Resistance to Molecularly Targeted Therapy in Non-Small Cell Lung Cancer.

Authors:  Kazuhiko Shien; Vassiliki A Papadimitrakopoulou; Dennis Ruder; Carmen Behrens; Li Shen; Neda Kalhor; Juhee Song; J Jack Lee; Jing Wang; Ximing Tang; Roy S Herbst; Shinichi Toyooka; Luc Girard; John D Minna; Jonathan M Kurie; Ignacio I Wistuba; Julie G Izzo
Journal:  Mol Cancer Ther       Date:  2017-07-20       Impact factor: 6.261

9.  Effects of general anesthesia with or without epidural block on tumor metastasis and mechanisms.

Authors:  Bin Yang; Feng Qian; Wenjia Li; Yang Li; Yangdong Han
Journal:  Oncol Lett       Date:  2018-01-26       Impact factor: 2.967

Review 10.  Classic and Novel Adipocytokines at the Intersection of Obesity and Cancer: Diagnostic and Therapeutic Strategies.

Authors:  Nikolaos Spyrou; Konstantinos I Avgerinos; Christos S Mantzoros; Maria Dalamaga
Journal:  Curr Obes Rep       Date:  2018-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.